Inhibrx Biosciences, Inc. INBX Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS estimate-$2.55
Next report
Aug 12, 2026 (in a month)EPS estimate-$2.28
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Inhibrx Biosciences, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Inhibrx Biosciences, Inc. report Q1 2025 earnings?
- Inhibrx Biosciences, Inc. (INBX) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Inhibrx Biosciences, Inc.'s Q1 2025 revenue and EPS?
- Inhibrx Biosciences, Inc. reported revenue of - and diluted EPS of $-2.80 for Q1 2025.
- Did Inhibrx Biosciences, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-2.55 by $0.25.
- How did Inhibrx Biosciences, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 94.4% from $-1.44.
- Where can I find Inhibrx Biosciences, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0002007919-25-000056) directly on SEC EDGAR. The filing index links above go to sec.gov.